Hypoxia and energetic tumour metabolism

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metabolism

Background:

• Hypoxia-inducible factor (HIF-1) is a key regulator of cellular adaptation to low-oxygen conditions, particularly in tumors.
• Genetic and epigenetic alterations also contribute to metabolic changes in hypoxic tumor cells.
• HIF-1 influences numerous cellular processes beyond metabolism, including proliferation and survival.

Purpose of the Study:

• To elucidate the role of HIF-1 in metabolic reprogramming of hypoxic tumor cells.
• To identify HIF-1-mediated adaptive survival mechanisms in cancer.
• To explore potential therapeutic strategies targeting HIF-1.

Main Methods:

• Analysis of HIF-1's role in metabolic shifts (oxidative phosphorylation to glycolysis).
• Investigation of HIF-1's involvement in adaptive survival mechanisms (e.g., angiogenesis, autophagy).
• Examination of HIF-1's function in regulating tumor acidosis (CA IX, MCT4).

Main Results:

• HIF-1 promotes cell proliferation via increased glycolysis and lactic acid production.
• HIF-1 mediates adaptive survival through epithelial-mesenchymal transition, angiogenesis, and autophagy.
• HIF-1 corrects tumor acidosis by upregulating carbonic anhydrase CA IX and MCT4.
• AMP-kinase is identified as a crucial regulator of cellular energy.

Conclusions:

• HIF-1 is central to cancer cell adaptation and survival under hypoxia.
• Targeting HIF-1-driven glycolysis and pH regulation presents novel therapeutic avenues.
• Inhibition of HIF-1 and AMP-kinase could be effective anti-cancer strategies.